IN2013MU02813A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02813A
IN2013MU02813A IN2813MU2013A IN2013MU02813A IN 2013MU02813 A IN2013MU02813 A IN 2013MU02813A IN 2813MU2013 A IN2813MU2013 A IN 2813MU2013A IN 2013MU02813 A IN2013MU02813 A IN 2013MU02813A
Authority
IN
India
Prior art keywords
saxagliptin
preparation
pharmaceutically acceptable
acceptable salts
improved
Prior art date
Application number
Other languages
English (en)
Inventor
Virendra Kumar Agarwal
Arif Badrulhusan Siddiqui
Lalit Keshav Kataria
Abhay Subodhbhai Maheta
Pankaj Changanbhai Butani
Shashikant Prabhakarrao Patil
Tushar Yashwant Patil
Ganesh Suryakant Deore
Ketan Jahyantibhai Pansuriya
Hitesh Sureshbhai Patel
Lalit Badhabhai Sondharava
Original Assignee
Amneal Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amneal Pharmaceuticals Llc filed Critical Amneal Pharmaceuticals Llc
Priority to US14/911,918 priority Critical patent/US9416105B2/en
Priority to PCT/US2014/053123 priority patent/WO2015031595A1/en
Priority to IN2813MU2013 priority patent/IN2013MU02813A/en
Publication of IN2013MU02813A publication Critical patent/IN2013MU02813A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2813MU2013 2013-08-28 2014-08-28 IN2013MU02813A (sr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/911,918 US9416105B2 (en) 2013-08-28 2014-08-28 Process for preparation of saxagliptin and its hydrochloride salt
PCT/US2014/053123 WO2015031595A1 (en) 2013-08-28 2014-08-28 A process for preparation of saxagliptin and its hydrochloride salt
IN2813MU2013 IN2013MU02813A (sr) 2013-08-28 2014-08-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2813MU2013 IN2013MU02813A (sr) 2013-08-28 2014-08-28

Publications (1)

Publication Number Publication Date
IN2013MU02813A true IN2013MU02813A (sr) 2015-07-03

Family

ID=52587325

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2813MU2013 IN2013MU02813A (sr) 2013-08-28 2014-08-28

Country Status (3)

Country Link
US (1) US9416105B2 (sr)
IN (1) IN2013MU02813A (sr)
WO (1) WO2015031595A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106349185B (zh) * 2016-08-26 2018-07-06 河北科技大学 一种氨基保护的3-羟基金刚烷甘氨酸苯并噻唑-2-硫醇活性酯、其制备方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US7420079B2 (en) 2002-12-09 2008-09-02 Bristol-Myers Squibb Company Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
TW200538122A (en) 2004-03-31 2005-12-01 Bristol Myers Squibb Co Process for preparing a dipeptidyl peptidase Ⅳ inhibitor and intermediates employed therein
US7214702B2 (en) 2004-05-25 2007-05-08 Bristol-Myers Squibb Company Process for producing a dipeptidyl peptidase IV inhibitor
PE20090696A1 (es) * 2007-04-20 2009-06-20 Bristol Myers Squibb Co Formas cristalinas de saxagliptina y procesos para preparar las mismas
WO2011140328A1 (en) 2010-05-05 2011-11-10 Teva Pharmaceutical Industries Ltd. Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof
EP2713730A4 (en) 2011-05-24 2015-08-05 Apicore Llc PROCESS FOR THE PREPARATION OF SAXAGLIPTIN AND ITS NEW INTERMEDIATES USEFUL IN ITS SYNTHESIS

Also Published As

Publication number Publication date
US9416105B2 (en) 2016-08-16
US20160194282A1 (en) 2016-07-07
WO2015031595A1 (en) 2015-03-05

Similar Documents

Publication Publication Date Title
PH12019500176A1 (en) Heterocyclic compounds and ther uses
IN2014CH00247A (sr)
IN2015DN01156A (sr)
EP2938616A4 (en) PROCESS FOR THE PREPARATION OF TOFACITINIB AND INTERMEDIATES
IN2014DN11201A (sr)
SG195114A1 (en) Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
WO2014125506A3 (en) A process for the preparation of ivacaftor and its intermediates
IN2012MU03723A (sr)
IN2013MU00848A (sr)
MX2015012416A (es) Compuestos heterociclicos y sus usos.
IN2013MU00646A (sr)
EP3189053A4 (en) An improved process for the preparation of apixaban and intermediates thereof
IN2014DN09450A (sr)
JOP20190163B1 (ar) منشط nrf2
IN2013MU03862A (sr)
WO2013190509A3 (en) Preparation of intermediates of boceprevir
IN2013MU01111A (sr)
EA201690263A1 (ru) Улучшенные способы получения перампанеля
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
NZ783086A (en) Concentrated gibberellin solution formulations
IN2013MU02813A (sr)
SG11201703330YA (en) Iminosugars useful for the treatment of viral diseases
IN2014CH01391A (sr)
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.